ERIC ROHREN to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications ERIC ROHREN has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.367
-
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience. Curr Radiopharm. 2018; 11(2):147-152.
Score: 0.136
-
Factors affecting (223)Ra therapy: clinical experience after 532 cycles from a single institution. Eur J Nucl Med Mol Imaging. 2016 Jan; 43(1):8-20.
Score: 0.116
-
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. J Nucl Med. 2015 Aug; 56(8):1177-84.
Score: 0.114